Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Sep 28;20(36):13167-71.
doi: 10.3748/wjg.v20.i36.13167.

Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer

Affiliations
Clinical Trial

Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer

Adam Durczynski et al. World J Gastroenterol. .

Abstract

Aim: To assess the value of D-dimer level in determining resectability of pancreatic cancer.

Methods: Preoperative prediction of pancreatic head cancer resectability remains inaccurate. The use of hemostatic factors may be of potential help, since D-dimers correlate with tumor stage. Single center clinical trial study comprised patients with potentially resectable pancreatic head tumor and without detectable venous thrombosis (n = 64). Resectability was defined as no evidence of nodal involvement, distant spread and no invasion of mesenteric vessels. Final decision of resectability was confirmed intraoperatively. Experienced pancreatic surgeon performed all surgeries. Following the dissection of hepatoduodenal ligament, samples of portal blood and bile were taken. Peripheral blood via central line and urine via Foley catheter were sampled. D-dimer levels were further measured.

Results: At laparotomy only 29 (45.3%) tumors were found to be resectable. Our analysis showed higher by 57.5% (P < 0.001) mean D-dimer values in peripheral and 43.7% (P = 0.035) in portal blood of patients with unresectable pancreatic cancer. Significant differences were not observed when analyzing D-dimer levels in bile and urine. Peripheral D-dimer level correlated with pancreatic cancer resectability. When cut-off D-dimer value of 570.6 μg/L was used, the sensitivity for assessment of tumor unresectability was 82.8%. Furthermore, D-dimer level in peripheral blood of metastatic disease (n = 15) was significantly higher when compared to locally advanced (n = 20) pancreatic cancer (2470 vs 1168, P = 0.029). The area under ROC curve for this subgroup of patients was 0.87; for determination of unresectable disease when threshold of 769.8 μg/L was used, sensitivity and specificity was 86.6% and 80%, respectively.

Conclusion: Patients with resectable pancreatic head cancer based on preoperative imaging studies and high D-dimer level may be considered unresectable due to occult hepatic metastases. These patients may benefit from diagnostic laparoscopy to avoid exploratory laparotomy.

Keywords: Bile; D-dimers; Pancreatic cancer; Pancreatic cancer respectability; Peripheral blood; Portal blood; Urine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Receiver operating characteristic curve analysis. A: D-dimer level in peripheral blood of patients with unresectable pancreatic cancer; area under curve: 0.7895, SE: 0.05; B: D-dimer levels in peripheral blood of patients with metastatic disease; area under curve: 0.8733, SE: 0.05. ROC: Receiver operating characteristic.

Similar articles

Cited by

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
    1. Moon HJ, An JY, Heo JS, Choi SH, Joh JW, Kim YI. Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. Pancreas. 2006;32:37–43. - PubMed
    1. Morgan DE, Waggoner CN, Canon CL, Lockhart ME, Fineberg NS, Posey JA, Vickers SM. Resectability of pancreatic adenocarcinoma in patients with locally advanced disease downstaged by preoperative therapy: a challenge for MDCT. AJR Am J Roentgenol. 2010;194:615–622. - PMC - PubMed
    1. Chiang KC, Yeh CN, Ueng SH, Hsu JT, Yeh TS, Jan YY, Hwang TL, Chen MF. Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer. World J Surg Oncol. 2012;10:77. - PMC - PubMed
    1. Mann O, Strate T, Schneider C, Yekebas EF, Izbicki JR. Surgery for advanced and metastatic pancreatic cancer--current state and perspectives. Anticancer Res. 2006;26:681–686. - PubMed

Publication types

MeSH terms

Substances